A Study of IMC-002 in Patients With Advanced Cancer Failed to Standard Therapy
A Study of IMC-002 in Patients With Advanced Cancer Failed to Standard Therapy
Recruiting · NCT05276310 · Registry updated 2026-09-25Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Study of IMC-002 in Patients With Advanced Cancer Failed to Standard Therapy | Advanced Cancer | Recruiting | Phase 1 | 2026-09-25 | NCT05276310 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| ImmuneOncia Therapeutics Inc. | 3 |
3 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Asan Medical Center, Republic of Korea | Seoul | South Korea | 1 |
| National Cancer Center | Goyang-si | South Korea | 23 |
| Samsung Medical Center | Seoul | South Korea | 170 |